Stock listing
Tradegate:2VF0 Hemostemix Inc Aktie
German listing (Tradegate) of Hemostemix Inc · home listing TSXV:HEM
Follow Hemostemix Inc into a list and get an email when it puts out news.
Home listing price · TSXV:HEM
$0.05 CAD -0.01 (-16.7%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:HEM
- Day range
- $0.045 – $0.06 CADNov 2, 2026
- Volume
- 56,712 sharesNov 2, 2026
- Market cap
- $10.57M CADAt the close on Nov 2, 2026 · price × 211.4M shares outstanding
- 52-week range
- $0.04 – $0.11 CADLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1,807 CADMedian day 7,000 shares · 8 days with no trades · last 3 months, Aug 4, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:HEM · Home | $0.05 CAD | -0.01 (-16.7%) | 56,712 | $0.06 | $0.06 | $0.045 | $0.06 | Close on Nov 2, 2026 |
| OTC:HMTXF | $0.041 USD | +0.001 (+1.5%) | 11,000 | $0.041 | $0.041 | $0.041 | $0.040 | Close on Oct 23, 2026 |
| Frankfurt:2VF0 | €0.028 EUR | -0.002 (-8.3%) | — | €0.025 | €0.028 | €0.025 | €0.030 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 2, 2026 · TSXV:HEM · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.05 | -0.01 | -16.7% | $0.06 | $0.06 | $0.045 | 56,712 | |
| $0.06 | 0.00 | 0.0% | $0.05 | $0.06 | $0.05 | 95,200 | |
| $0.06 | +0.005 | +9.1% | $0.06 | $0.06 | $0.05 | 73,000 | |
| $0.055 | 0.00 | 0.0% | $0.06 | $0.06 | $0.055 | 6,300 | |
| $0.055 | 0.00 | 0.0% | $0.06 | $0.06 | $0.055 | 28,274 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 2,000 | |
| $0.06 | +0.005 | +9.1% | $0.06 | $0.06 | $0.06 | 1,000 | |
| $0.055 | 0.00 | 0.0% | $0.065 | $0.065 | $0.05 | 111,300 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 2,100 | |
| $0.06 | 0.00 | 0.0% | $0.055 | $0.06 | $0.055 | 15,000 | |
| $0.06 | 0.00 | 0.0% | $0.055 | $0.065 | $0.055 | 37,150 | |
| $0.06 | 0.00 | 0.0% | $0.055 | $0.06 | $0.055 | 11,000 | |
| $0.06 | -0.015 | -20.0% | $0.06 | $0.06 | $0.055 | 251,900 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 0 | |
| $0.075 | +0.01 | +15.4% | $0.07 | $0.075 | $0.07 | 11,800 | |
| $0.065 | 0.00 | 0.0% | $0.065 | $0.065 | $0.065 | 7,000 | |
| $0.065 | 0.00 | 0.0% | $0.065 | $0.065 | $0.065 | 0 | |
| $0.065 | +0.005 | +8.3% | $0.055 | $0.065 | $0.055 | 21,700 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 0 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 5,000 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 1,100 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 1,000 | |
| $0.06 | +0.005 | +9.1% | $0.06 | $0.06 | $0.06 | 7,100 | |
| $0.055 | -0.01 | -15.4% | $0.055 | $0.055 | $0.055 | 10,000 | |
| $0.065 | 0.00 | 0.0% | $0.06 | $0.065 | $0.06 | 10,000 | |
| $0.065 | -0.005 | -7.1% | $0.07 | $0.07 | $0.06 | 269,500 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 2,600 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 50,000 | |
| $0.07 | -0.005 | -6.7% | $0.07 | $0.07 | $0.07 | 4,000 | |
| $0.075 | +0.005 | +7.1% | $0.075 | $0.075 | $0.075 | 14,100 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | -0.005 | -6.7% | $0.07 | $0.07 | $0.07 | 2,000 | |
| $0.075 | +0.005 | +7.1% | $0.075 | $0.075 | $0.07 | 21,800 | |
| $0.07 | -0.005 | -6.7% | $0.07 | $0.07 | $0.07 | 37,900 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 15,900 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 2,000 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 1,700 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 2,800 | |
| $0.075 | +0.005 | +7.1% | $0.075 | $0.075 | $0.075 | 3,000 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 5,001 | |
| $0.07 | -0.005 | -6.7% | $0.075 | $0.075 | $0.07 | 22,844 | |
| $0.075 | -0.005 | -6.3% | $0.075 | $0.075 | $0.075 | 20,410 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 0 | |
| $0.08 | +0.005 | +6.7% | $0.075 | $0.08 | $0.075 | 59,000 | |
| $0.075 | +0.005 | +7.1% | $0.075 | $0.075 | $0.075 | 1,900 | |
| $0.07 | -0.005 | -6.7% | $0.07 | $0.07 | $0.07 | 1,300 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.08 | $0.075 | 113,300 | |
| $0.075 | -0.005 | -6.3% | $0.075 | $0.075 | $0.075 | 5,600 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 0 | |
| $0.08 | +0.005 | +6.7% | $0.075 | $0.08 | $0.075 | 11,000 | |
| $0.075 | 0.00 | 0.0% | $0.075 | $0.075 | $0.075 | 1,000 | |
| $0.075 | +0.01 | +15.4% | $0.075 | $0.075 | $0.07 | 11,900 | |
| $0.065 | -0.005 | -7.1% | $0.065 | $0.065 | $0.065 | 3,800 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.065 | 124,600 | |
| $0.07 | +0.005 | +7.7% | $0.07 | $0.07 | $0.07 | 25,800 | |
| $0.065 | 0.00 | 0.0% | $0.065 | $0.065 | $0.065 | 0 | |
| $0.065 | -0.005 | -7.1% | $0.065 | $0.065 | $0.065 | 83,800 | |
| $0.07 | +0.005 | +7.7% | $0.07 | $0.07 | $0.07 | 1,000 | |
| $0.065 | 0.00 | 0.0% | $0.07 | $0.07 | $0.065 | 5,500 | |
| $0.065 | +0.005 | +8.3% | $0.065 | $0.065 | $0.065 | 8,900 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 0 |
- Ticker
- Tradegate:2VF0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 7, 2026
Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update
Latest deck · 2026
Investor Presentation (2026)
Investor deck · 23 slides
Latest news
Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update
Oct 7, 2026
Closed $0.065 (0.0%) on Oct 7, 2026
Hemostemix to Attend Centurion One Capital's 4th Annual Bahamas Summit
Sep 28, 2026
Closed $0.06 (+9.1%) on Sep 28, 2026
Hemostemix Non Brokered Private Placement
Sep 23, 2026
Closed $0.065 (0.0%) on Sep 24, 2026
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
Aug 20, 2026
Closed $0.08 (0.0%) on Aug 20, 2026
Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell(TM) Longevity Clinical Trial
Aug 12, 2026
Closed $0.07 (+7.7%) on Aug 12, 2026
Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026
Jul 30, 2026
Closed $0.06 (0.0%) on Jul 31, 2026
Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell(TM)'s Excellent Results
Jul 28, 2026
Closed $0.07 (+16.7%) on Jul 28, 2026
Hemostemix grants 6,280,000 options
Jul 22, 2026
Closed $0.06 (0.0%) on Jul 23, 2026
Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain
Jul 8, 2026
Closed $0.06 (+33.3%) on Jul 8, 2026
Hemostemix Closes $360,000 First Tranche of Private Placement
Jun 26, 2026
Closed $0.055 (0.0%) on Jun 26, 2026
Financings
Private placement of units
Oct 7, 2026
Tranche closed: C$380,500 in the latest tranche · C$0.05 a unit · ½ warrant at C$0.12 for 24 months
Use of proceeds: ACP-01 manufacturing, clinical-program preparation, regulatory submissions, physician education and general working capital
Tranche closed Jul 30, 2026 · Update Sep 23, 2026 · Tranche closed Oct 7, 2026
Decks
Investor Presentation (2026)
Investor deck · 23 slides · 2026
Investor Presentation (2025)
Investor deck · 22 slides · Nov 3, 2025
Investor Presentation (April 2023)
Investor deck · 24 slides · April 2023
Investor Presentation (March 2022)
Investor deck · 18 slides · Mar 29, 2022
Hemostemix Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 35 in the last 12 months · 216 in all · newest Oct 7, 2026 · oldest 2013
- Decks
- 5 decks · latest 2026
Where Hemostemix Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:HEM · Home listing | TSXV | Canada | CAD |
| OTC:HMTXF | OTC | United States | USD |
| LS Exchange:A2QQGU | LS Exchange | Germany | EUR |
| Cboe Canada:HEM | Cboe Canada | Canada | CAD |
| Frankfurt:2VF0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QQGU | Lang & Schwarz | Germany | EUR |
| Stuttgart:2VF0 | Stuttgart | Germany | EUR |
| Tradegate:2VF0 · This page | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Hemostemix Inc.